期刊文献+

化疗对CD133+结肠癌细胞的作用效果 被引量:4

Effect of chemotherapy on CD133^+ colon cancer cells
原文传递
导出
摘要 目的观察化疗前后结肠癌细胞株HT29、SW620中CD133^+结肠癌细胞的数量变化,探讨化疗对CD133^+结肠癌细胞的作用效果。方法取对数生长的结肠癌细胞株HT29、SW620,采用80mg/L5-氟尿嘧啶(5.Fu)和25mg/L奥沙利铂(Oxaliplatin)分别作用8h,并设对照组,利用CD133抗体进行标记后再用流式细胞仪进行检测,观察化疗前后CD133^+细胞的比例。结果流式细胞仪检测结肠癌细胞株HT29,80mg/L5-Fu处理8h组中CD133^+肿瘤细胞为45.00%,与未处理组(32.80%)比较结果差异有统计学意义(P〈0.01);25mg/L奥沙利铂处理8h组中CD133^+肿瘤细胞为55.30%,与未处理组和80mg/L5-Fu处理8h组比较结果差异有统计学意义(P〈0.01)。流式细胞仪检测结肠癌细胞株SW620,80mg/L5-Fu处理8h组中CD133^+肿瘤细胞为47.10%,与未处理组(33.90%)比较结果差异有统计学意义(P〈0.01);25mg/L奥沙利铂处理8h组中CD133。肿瘤细胞为56.50%,与未处理组和80mg/L5-Fu处理8h组比较结果差异有统计学意义(P〈0.01)。结论CD133^+结肠癌细胞能明显抵抗化疗。 Objective To observe the changes of quantity of CD133 + cells in HT29 and SW620 cell lines before and after chemotherapy, and detect the effect of chemotherapy on CD133 + cells. Methods HT29 and SW620 cells in logarithmic growth phase were separately treated with 80 mg/L 5-fluorouracil (5-Fu) and 25 mg/L oxaliplatin for 8 h, and analyzed by flow cytometry after being marked by CD1339 antibody. The proportion of CD133 + cells before and after chemotherapy was measured. Results For HT29 ceils, the proportion of CD133 + cancer cells in the group treated with 80 mg/L 5-Fu for 8h was 45.00% with the difference being remarkable ( P 〈 0. 01 ) compared to the non-treatment group ( 32. 80% ). The proportion of CD133 + cancer cells in the group treated with 25 mg/L oxaliplatin for 8 h was 55.30% with the difference being remarkable ( P 〈 O. 01 ) compared with both the non-treatment group and the group treated with 80 mg/L 5-Fu for 8 h. For SW620 cells, the proportion of CD133 + cancer cells in the group treated with 80 mg/L 5-Fu for 8 h was 47. 10% with the difference being remarkable (P 〈 0. 01 ) compared with the non-treatment group (33.90%). The proportion of CD133 + cancer cells in the group treated with 25 mg/L oxaliplatin for 8 h was 56. 50% with the difference being remarkable ( P 〈 0. 01 ) compared with both the non-treatment group and the group treated with 80 mg/L 5-Fu for 8 h. Conclusion CD133 positive colon cancer cells have anti-chemotherapy activity obviously.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第1期30-31,共2页 Chinese Journal of Experimental Surgery
关键词 结肠癌细胞 化疗 CD133 Colon carcinoma Chemotherapy CD133
  • 相关文献

参考文献7

二级参考文献57

  • 1史朝晖,姜希宏,赵峰,王伟.RelA反义寡核苷酸对胰腺癌细胞增殖活性的影响[J].中华实验外科杂志,2004,21(8):917-919. 被引量:3
  • 2焦志军,王文红,杨友.AnnexinⅤ-FITC/PI双标记流式细胞术检测结直肠癌细胞凋亡[J].江苏大学学报(医学版),2005,15(2):97-99. 被引量:14
  • 3周静,赵刚,刘涛,王春友.实体肿瘤干细胞的研究进展[J].中华实验外科杂志,2006,23(1):122-123. 被引量:24
  • 4Jung GR, Kim KJ, Choi CH, et al. Effect of betulinic acid on anticancer drugresistant colon cancer cells [J]. Basic Clin Pharmacol Toxicol, 2007,101(4):277-285.
  • 5Watson AJ. Apoptosis and colorectal cancer [J]. Gut, 2004,53 (11):1701-1709.
  • 6Martin DA, Elkon KB. Mechanisms of apoptosis [J]. Rheum Dis Clin North Am, 2004,30(3):441 - 454.
  • 7Rigas A, Dervenis C, Giannakou N, et al. Selective induction of colon cancer cell apoptosis by 5-fluorouracil in humans [J]. Cancer Invest, 2002,20(5-6):657-665.
  • 8Freyer G, Ligneau B, Kraft D, et al. Therapeutic advances in the management of metastatic colorectal cancer [J]. Expert Rev Anticancer Ther, 2001,1 (2):236-246.
  • 9Leonardi V, Savio G, Laudani A, et al. New approaches to breast cancer combined with 5-fluorouracil and folinic acid in pretreated advanced breast cancer patients:preliminary reports [J]. Ann N Y Acad Sci,2002,963(6):91-97.
  • 10Rosell R, Crino L. Pemetrexed combination therapy in the treatment of non-small cell lung cancer [J]. Semin Oncol, 2002,29(2 suppl 5):23-29.

共引文献51

同被引文献28

  • 1Hambardzumyan D,Squartro M,Holland EC.Radiation resistance and stem-like cells in brain tumors[J].中国神经肿瘤杂志,2006,4(4). 被引量:34
  • 2Alba Rocco,Debora Compare,Gerardo Nardone.Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions[J].World Journal of Gastrointestinal Oncology,2012,4(3):54-59. 被引量:11
  • 3Prud' homme GJ. Cancer stem cells and novel targets for antitumor strategies. Curt ]?harm Des ,2012,18:2838-2849.
  • 4Zhang Y, Wei J, Wang H, et al. Epithelial mesenchymal transition cor- relates with CD24 + CD44 + and CD133 + cells in pancreatic canc- er. Oneol Rep ,2012,27 : 1599-1605.
  • 5Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchy- mal transition: concepts and molecular links. Semin Cancer Biol, 2012.22:396-403.
  • 6Bellizzi A,Sebastian S,Ceglia P,et al. Co-expression of CD133 ( + ) /CD44( + ) in human colon cancer and liver metastasis. J Cell Phys- iol,2013,228:408-415.
  • 7Sanders MA, Majumdar AP. Colon cancer stem cells:implications in carcinogenesis. Front Biosci, 2011,16 : 1651 -1662.
  • 8Lin CW, Liao MY, Lin WW, et al. Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reproam- ming factors and epithelial-mesenchymal transition genes expression in colon cancer. J Biol Chem, 2012,287:39449-39459.
  • 9Golebiewska A, Brons NH, Bjerkvig R, et al. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell, 2011,8 : 136 -147.
  • 10Rybak AP, He L, Kapoor A, et al. Characterization of sphere-propaga- ting ceils with stem-like properties from DU145 prostate cancer cells. Bioehim Biophys Aeta,2011,1813 :683-694.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部